News

CIT Invests in EVS Glaucoma Therapeutics

CIT announced today that its CIT GAP Funds has closed an investment with EVS Glaucoma Therapeutics (EGT), a Herndon-based spinout of Euclid Vision Systems...

CIT GAP Funds Invests in WealthForge

CIT announced today that its CIT GAP Funds has closed an investment in WealthForge Holdings, Inc., a Richmond-based company that runs a complete, cost-effective...

CIT GAP Funds Hires Dan Henderson as Investment Director

The Center for Innovative Technology (CIT) announced today the appointment of Dan Henderson as Investment Director for CIT GAP Funds.

CIT GAP Funds

Who We Are:

CIT GAP Funds is a family of seed- and early-stage investment funds placing near-equity and equity investments in Virginia-based technology, life science, and cleantech companies.  CIT GAP Funds invests in companies with a high potential for achieving rapid growth and generating significant economic return for entrepreneurs, co-investors and the Commonwealth of Virginia.  CIT’s family of funds includes:

  • GAP Fund I – A vintage 2004 fund fully invested in a broad array of seed-stage technology companies. Portfolio.
  • GAP BioLife Fund – A seed fund investing exclusively in life science companies. 
  • GAP Tech Fund – A seed fund investing in IT and technology companies.
  • Commonwealth Energy Fund (CEF), a seed fund investing in energy efficiency and renewable energy companies. 

Follow CIT GAP Funds on: